Trial Profile
A Clinical Study Continued From the Confirmatory Study to Validate the Efficacy and Safety of Pimecrolimus Cream in Pediatric Atopic Dermatitis Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Pimecrolimus (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Sponsors Novartis
- 20 May 2016 New trial record